TGF-beta1 Induced Islet Antigen-Specific Tolerance in Type 1 Diabetes
TGF-beta1 Induced Islet Antigen-Specific Tolerance in Type 1 Diabetes
批准号:
7288214
负责人:
Xunrong Luo
金额:
$12.72万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-20 至 2011-08-31
关键词:
AddressAdenovirusesAdverse effectsAntigen PresentationAntigensAutoimmune DiabetesAutoimmune ProcessCell physiologyCellsCombined Modality TherapyConditionCoupledDataDedicationsDendritic CellsDevelopmentDiabetes MellitusDiabetic mouseDiseaseElementsEnvironmentGoalsGraft SurvivalGrowth FactorHumanImageImmunosuppressionIn VitroInbred NOD MiceInsulinInsulin-Dependent Diabetes MellitusLearningLifeMethodologyNatural regenerationNatureNon obesePancreasPathogenesisPatientsPeripheralPlayPopulationProcessResearchResearch PersonnelResearch ProposalsResearch TrainingRiskRoleSelf ToleranceSourceSpecificityT-Cell ProliferationT-Cell ReceptorT-LymphocyteTechnologyTestingTherapeutic immunosuppressionTransgenic OrganismsTransplantationTreatment EfficacyUniversitiesbasecareercell growthdesigndiabetichuman TGFB1 proteinin vivoinsulin secretionisletmedical schoolsmouse modelnovelpreventprogramsprotective effectresearch studysizetheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The long-term objective of this proposal is to design a novel immunomodulatory therapy for tolerance induction for treatment of autoimmune (type 1) diabetes. The specific aim of the proposal is to test a transforming growth factor-beta 1 (TGF-beta1) based methodology for inducing islet antigen-specific regulatory T cells that are capable of transferring self-tolerance in the mouse model of human type 1 diabetes. The potential findings from this research proposal would have significant implications in treatment of patients with type 1 diabetes.
The candidate will perform the proposed studies using the non-obese diabetic (NOD) mouse model of human type 1 diabetes. The step-wise approach for pursuing these goals will be: (1) to induce TGF-beta1 dependent islet antigen-specific regulatory T cells from a polyclonal naive T cell population, using dendritic cells for selecting antigen specificities; (2) to test the therapeutic efficacy of the TGF-beta 1-induced regulatory T cells in reverting established diabetes in the NOD mouse; and (3) to determine the potential endogenous source(s) of TGF-beta1, particularly among dendritic cell subsets which are newly recognized to play an important role in tolerance induction.
Current treatment for human type 1 diabetes requires life-long insulin therapy or long-term immunosuppression for transplantation, both of which have significant risks and unwanted side-effects. Successful completion of the proposed project will help us design immunomodulatory therapies that specifically target the autoimmune process for treatment of this devastating disease.
In addition to having intrinsic research importance, the proposed research contains the necessary components of serving as a suitable vehicle for learning the methodology, theories, and conceptualizations necessary for transition of the candidate to an independent investigator. Together with the conducive environment at Northwestern University Feinberg School of Medicine, the dedication and commitment of the candidate's sponsor and co-sponsors to the candidate's career development, and the candidate's accomplished research background, this proposed research and training would provide the central force for bringing these elements together and ultimately contribute to fulfillment of the candidate's career goal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Donor Kidney Resident Macrophages in Kidney Allograft Early Inflammation and Alloimmunity
-
批准号:10467170
-
项目类别:
-
资助金额:$48.47万
-
财政年份:2022
-
负责人:Xunrong Luo
-
依托单位:
Donor Kidney Resident Macrophages in Kidney Allograft Early Inflammation and Alloimmunity
-
批准号:10588212
-
项目类别:
-
资助金额:$48.47万
-
财政年份:2022
-
负责人:Xunrong Luo
-
依托单位:
Therapeutics Development Core (Core B)
-
批准号:10203939
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2018
-
负责人:Xunrong Luo
-
依托单位:
Therapeutics Development Core (Core B)
-
批准号:10460933
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2018
-
负责人:Xunrong Luo
-
依托单位:
Determinants of donor-specific T cell tolerance in kidney transplantation in non-sensitized recipients
-
批准号:10622059
-
项目类别:
-
资助金额:$109.12万
-
财政年份:2017
-
负责人:Xunrong Luo
-
依托单位:
Modeling concurrent cytomegalovirus infection and transplantation tolerance
-
批准号:9240574
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2016
-
负责人:Xunrong Luo
-
依托单位:
Modeling concurrent cytomegalovirus infection and transplantation tolerance
-
批准号:9028961
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2016
-
负责人:Xunrong Luo
-
依托单位:
Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy
-
批准号:9302428
-
项目类别:
-
资助金额:$52.3万
-
财政年份:2010
-
负责人:Xunrong Luo
-
依托单位:
Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy
-
批准号:8886518
-
项目类别:
-
资助金额:$55.87万
-
财政年份:2010
-
负责人:Xunrong Luo
-
依托单位:
ECDI Coupled Cells for Tolerance in Allogeniec Islet Cell Transplantation for T1D
-
批准号:8001130
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:Xunrong Luo
-
依托单位:
Clinical Islet Transplantation at Northwestern
-
批准号:7941899
-
项目类别:
-
资助金额:$127.46万
-
财政年份:2009
-
负责人:Xunrong Luo
-
依托单位:
Clinical Islet Transplantation at Northwestern
-
批准号:8117131
-
项目类别:
-
资助金额:$53.38万
-
财政年份:2009
-
负责人:Xunrong Luo
-
依托单位:
ECDI Coupled Cells for Tolerance in Allogeniec Islet Cell Transplantation for T1D
-
批准号:8139432
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2008
-
负责人:Xunrong Luo
-
依托单位:
TGF-beta1 Induced Islet Antigen-Specific Tolerance in Type 1 Diabetes
-
批准号:7679479
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2006
-
负责人:Xunrong Luo
-
依托单位:
TGF-beta1 Induced Islet Antigen-Specific Tolerance in Type 1 Diabetes
-
批准号:7482341
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2006
-
负责人:Xunrong Luo
-
依托单位:
TGF-beta1 Induced Islet Antigen-Specific Tolerance in Type 1 Diabetes
-
批准号:7920864
-
项目类别:
-
资助金额:$9.19万
-
财政年份:2006
-
负责人:Xunrong Luo
-
依托单位:
TGF-beta1 Induced Islet Antigen-Specific Tolerance in Type 1 Diabetes
-
批准号:7147386
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2006
-
负责人:Xunrong Luo
-
依托单位:
MCMV infection, latency and reactivation in transplantation tolerance
-
批准号:8934957
-
项目类别:
-
资助金额:$37.77万
-
财政年份:--
-
负责人:Xunrong Luo
-
依托单位:
Therapeutics Development Core (Core B)
-
批准号:9753229
-
项目类别:
-
资助金额:$26.13万
-
财政年份:--
-
负责人:Xunrong Luo
-
依托单位:
海外基金